InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: Titan V post# 2684

Saturday, 05/21/2016 6:57:40 PM

Saturday, May 21, 2016 6:57:40 PM

Post# of 231513
Actually this article really confirms what CYDY has seen in adjunct therapy trial - much slower enrollment - despite having 25 sites activated - 8 were closed maybe due to low participation.

Dr P has confirmed that they have contracted same CRO for monotherapy - this could mean that existing sites will be used for enrollment - this could create conflict of enrollment between 2 sites - that may be reason why Dr P said that monotherapy enrollment may complete 1st. They may divert patients to monotherapy before adjunct therapy

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News